4basebio PLC (4BB.L)
GBp 1125.0
(-0.44%)
GBp 1125.0
(-0.44%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.34 Million GBP | -17.34% |
| 2022 | -5.4 Million GBP | -68.66% |
| 2021 | -3.2 Million GBP | -829.57% |
| 2020 | -346 Thousand GBP | -104.14% |
| 2019 | -136 Thousand GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.73 Million GBP | 0.0% |
| 2024 Q1 | -2.73 Million GBP | -33.3% |
| 2023 Q4 | -2.05 Million GBP | 0.0% |
| 2023 FY | - GBP | -17.34% |
| 2023 Q2 | -2.95 Million GBP | -69.05% |
| 2023 Q1 | -1.74 Million GBP | 24.07% |
| 2023 Q3 | -2.05 Million GBP | 30.59% |
| 2022 Q2 | -2.07 Million GBP | -67.52% |
| 2022 Q1 | -1.23 Million GBP | 5.46% |
| 2022 FY | - GBP | -68.66% |
| 2022 Q4 | -2.3 Million GBP | -61.04% |
| 2022 Q3 | -1.42 Million GBP | 31.04% |
| 2021 Q1 | -834.5 Thousand GBP | -220.96% |
| 2021 Q4 | -1.3 Million GBP | -55.93% |
| 2021 Q3 | -839.5 Thousand GBP | 46.9% |
| 2021 FY | - GBP | -829.57% |
| 2021 Q2 | -1.58 Million GBP | -89.45% |
| 2020 FY | - GBP | -104.14% |
| 2020 Q4 | -260 Thousand GBP | -161.31% |
| 2020 Q3 | -99.5 Thousand GBP | 47.63% |
| 2020 Q2 | -190 Thousand GBP | -50.2% |
| 2020 Q1 | -126.5 Thousand GBP | 0.0% |
| 2019 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|